Company attributes
Other attributes
Deep 6 AI, formerly known as Deep 6 Analytics, is a company attempting to revolutionize the way patients are selected and identified for clinical/ research trials. By using a Natural Language Processing AI, Deep 6 is able to sort through medical charts and clinical trials to create suitable trial:patient matches in minutes. Deep 6 has secured a contract with the U.S. Intelligence Community as a result of its effectiveness. Deep 6 has exclusively focused on providing for the medical community since 2016 when it participated in the Class 72 - Healthcare 2016 Spring cohort of Techstars.
A funding round conducted for Deep 6 AI, November, 2019, was a series A funding round that amassed $17 million in investments, with the lead investor being Point72 Ventures. Previously in March of 2016, a seed funding round took place with investments from UnitedHealthCare Accelerator Powered by Techstar, Techstar, and Cedars-Sinai Accelerator.
